Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity

v3.24.1.1.u2
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock
2022 Private Placement.
Common Stock
Additional Paid-in Capital
2022 Private Placement.
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
2022 Private Placement.
Total
Balance at Jun. 30, 2022   $ 34   $ 358,635   $ (209,198)   $ 149,471
Balance (in shares) at Jun. 30, 2022   33,582            
Gross proceeds from issuance of common stock for cash $ 3   $ 12,327       $ 12,330  
Gross proceeds from issuance of common stock for cash (in shares) 3,245              
Underwriting commissions and other equity offering costs       (759)       (759)
Share-based compensation       5,465       5,465
Net change in accumulated other comprehensive loss         $ (132)     (132)
Net Income (Loss)           (39,059)   (39,059)
Balance at Mar. 31, 2023   $ 37   375,668 (132) (248,257)   127,316
Balance (in shares) at Mar. 31, 2023   36,827            
Balance at Jun. 30, 2022   $ 34   358,635   (209,198)   149,471
Balance (in shares) at Jun. 30, 2022   33,582            
Net Income (Loss)               (51,800)
Balance at Jun. 30, 2023   $ 37   377,471 (351) (260,985)   116,172
Balance (in shares) at Jun. 30, 2023   36,827            
Balance at Dec. 31, 2022   $ 37   373,813   (232,585)   141,265
Balance (in shares) at Dec. 31, 2022   36,827            
Share-based compensation       1,855       1,855
Net change in accumulated other comprehensive loss         (132)     (132)
Net Income (Loss)           (15,672)   (15,672)
Balance at Mar. 31, 2023   $ 37   375,668 (132) (248,257)   127,316
Balance (in shares) at Mar. 31, 2023   36,827            
Balance at Jun. 30, 2023   $ 37   377,471 (351) (260,985)   116,172
Balance (in shares) at Jun. 30, 2023   36,827            
Issuance of common stock upon exercise of stock options       10       $ 10
Issuance of common stock upon exercise of stock options (in shares)   5           5
Share-based compensation       5,589       $ 5,589
Exercise of pre-funded warrants   $ 6   (6)        
Exercise of pre-funded warrants (in shares)   6,300            
Acquisition and retirement of treasury shares pursuant to Exchange Agreement   $ (3)   (5,697)       (5,700)
Acquisition and retirement of treasury shares pursuant to Exchange Agreement (in shares)   (3,000)            
Net change in accumulated other comprehensive loss         273     273
Net Income (Loss)           (45,483)   (45,483)
Balance at Mar. 31, 2024   $ 40   377,367 (78) (306,468)   70,861
Balance (in shares) at Mar. 31, 2024   40,132            
Balance at Dec. 31, 2023   $ 40   381,154 (48) (289,418)   91,728
Balance (in shares) at Dec. 31, 2023   39,625            
Issuance of common stock upon exercise of stock options       10       10
Issuance of common stock upon exercise of stock options (in shares)   5            
Share-based compensation       1,903       1,903
Exercise of pre-funded warrants   $ 3   (3)        
Exercise of pre-funded warrants (in shares)   3,502            
Acquisition and retirement of treasury shares pursuant to Exchange Agreement   $ (3)   (5,697)       (5,700)
Acquisition and retirement of treasury shares pursuant to Exchange Agreement (in shares)   (3,000)            
Net change in accumulated other comprehensive loss         (30)     (30)
Net Income (Loss)           (17,050)   (17,050)
Balance at Mar. 31, 2024   $ 40   $ 377,367 $ (78) $ (306,468)   $ 70,861
Balance (in shares) at Mar. 31, 2024   40,132